TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Journalists invited to cover the 2026 two sessions
- Xi's vision for China's winter sports
- China's social security funds post 10-trillion-yuan balance at end of 2025
- China drafts policies to buoy job market amid tech, trade shift
- Chinese scientists identify key Ebola virus mutation
- University of Chinese Academy of Sciences unveils the School of Space Exploration
